Selecta Biosciences Inc - ESG Rating & Company Profile powered by AI
Full ESG analysis of Selecta Biosciences Inc are reached by signing up for free. The webpage is a free Environmental, Social and Governance assessment covering Selecta Biosciences Inc. This assessment of Selecta Biosciences Inc leverages data points from across the internet and also from available filings by Selecta Biosciences Inc.
Selecta Biosciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.6; made up of an environmental score of 4.8, social score of 4.8 and governance score of 4.0.
4.6
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 1156 | Vectus Biosystems Ltd | 4.7 | High |
| 1156 | Zynerba Pharmaceuticals Inc | 4.7 | High |
| 1199 | Selecta Biosciences Inc | 4.6 | High |
| 1199 | Allergan Inc | 4.6 | High |
| 1199 | AroCell AB (publ) | 4.6 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Selecta Biosciences Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Selecta Biosciences Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Selecta Biosciences Inc report the average age of the workforce?
Sign up for free to unlockDoes Selecta Biosciences Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Selecta Biosciences Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Selecta Biosciences Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Selecta Biosciences Inc offer flexible work?
Sign up for free to unlockDoes Selecta Biosciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Selecta Biosciences Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Selecta Biosciences Inc conduct supply chain audits?
Sign up for free to unlockDoes Selecta Biosciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Selecta Biosciences Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Selecta Biosciences Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Selecta Biosciences Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Selecta Biosciences Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Selecta Biosciences Inc disclose water use targets?
Sign up for free to unlockDoes Selecta Biosciences Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Selecta Biosciences Inc have a product recall in the last two years?
Sign up for free to unlockDoes Selecta Biosciences Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Selecta Biosciences Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Selecta Biosciences Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Selecta Biosciences Inc disclose parental leave metrics?
Sign up for free to unlockDoes Selecta Biosciences Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Selecta Biosciences Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Selecta Biosciences Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Selecta Biosciences Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Selecta Biosciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Selecta Biosciences Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Selecta Biosciences Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Selecta Biosciences Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Selecta Biosciences Inc disclose its waste policy?
Sign up for free to unlockDoes Selecta Biosciences Inc report according to TCFD requirements?
Sign up for free to unlockDoes Selecta Biosciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Selecta Biosciences Inc disclose energy use targets?
Sign up for free to unlockDoes Selecta Biosciences Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Selecta Biosciences Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Selecta Biosciences Inc
These potential risks are based on the size, segment and geographies of the company.
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. It is also developing biologic therapies, such as SEL-212 that is in Phase III clinical trials for the treatment of chronic refractory gout; and product candidates to treat IgA-mediated diseases, including IgA nephropathy, linear IgA bullous dermatitis, IgA pemphigus, and Henoch-Schonlein purpura. In addition, the company is developing gene therapies comprising SEL-313, a product candidate in preclinical stage to treat ornithine transcarbamylase deficiency; SEL-399, a product candidate to evaluate the appropriate dose of ImmTOR in humans to reduce the formation of antibodies to AAV capsids; and products for the treatment of pompe disease, duchenne muscular dystrophy, limb-girdle muscular dystrophy, lysosomal storage disorder, and other autoimmune diseases. Further, it develops tolerogenic therapies to treat primary biliary cholangitis and other autoimmune diseases. The company has license and collaboration agreements with Takeda Pharmaceuticals USA, Inc.; Swedish Orphan Biovitrum; Sarepta Therapeutics, Inc.; Asklepios Biopharmaceutical, Inc.; Massachusetts Institute of Technology; Shenyang Sunshine Pharmaceutical Co., Ltd.; Ginkgo Bioworks Holdings, Inc.; and IGAN Biosciences, Inc. Selecta Biosciences, Inc. was incorporated in 2007 and is headquartered in Watertown, Massachusetts.